The CCK-8 assay and flow cytometry results demonstrated that TRIM6 overexpression in MOLM-13 and Kasumi-1 AML cells inhibited cell proliferation, altered cell cycle progression, and promoted apoptosis. The gene discussed is TRIM6; the disease is acute myeloid leukemia.